Page results
-
Patient information for patients who have been recommended to use a Polymem® dressing on your skin that has broken down due to radiotherapy or proton beam therapy treatment.
-
Patient information for patients who have been recommended to use a Mepilex® dressing on their skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
The special haematology service provides a comprehensive investigation of haemolytic amaemia, haemoglobinopathies and red cell enzymopathy.
-
This page has been written for patients who are receiving proton beam therapy (PBT) to the prostate.
-
The UCLH Department of Rheumatology is a UK centre of excellence for clinical care, training and research.
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.
File results
-
FOI/2022/0407 - Rooftop and greenfield mobile mast site agreements
-
FOI/2022/0411 - Resident Medical Officers/ Resident Doctors/ Senior House Officers supplied by agencies
-
FOI/2022/0421 - Paediatric autoimmune neuropsychiatric disorders
-
FOI/2022/0422 - Annual salary directors
-
FOI/2022/0443 - Trust spend on lost, stolen or damaged patient property
-
FOI/2022/0465 - Treatment of dermatological conditions
-
FOI/2022/0470 - Total spend on agency staff
-
FOI/2022/0485 - ACR laboratory device
-
FOI/2022/0486 - Dermatology dept staff details
-
FOI/2022/0488 - Robotic process automation